271 RESULTS
RESEARCH NEWS 2019-05-18 Research News Mysterious factors in the blood are known to trigger aging in the brain. Though researchers have yet to discover the identities of all these aging agents, they have pegged a protein that lets them do their dirty work. On May 13 in Nature Med
RESEARCH NEWS 2019-05-22 Research News Two studies offer new potential ways of quelling the neuron-killing rampage of the C9ORF72 hexanucleotide expansion, the biggest genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). In one, a mouse model fe
CONFERENCE COVERAGE 2019-05-22 Conference Coverage At the American Academy of Neurology’s 71st Annual Meeting, held May 4–10 in Philadelphia, researchers showcased their latest data on antisense oligonucleotides (ASOs). These short, synthetic, single-stranded oligodeoxynucleotides bind
RESEARCH NEWS 2019-05-24 Research News Does neurogenesis keep the brain sharp? This unsettled debate is getting new fuel this week. In the May 23 Cell Stem Cell online, researchers led by Orly Lazarov at the University of Illinois, Chicago, report that they can find newborn neuro
CONFERENCE COVERAGE 2019-05-24 Conference Coverage About 140 scientists gathered in Rungstedgaard, north of Copenhagen, Denmark, May 5–9 for the biannual Brain Conference organized by the Federation of European Neuroscience Societies and the Lundbeck Foundation. Co-chaired by Beth Stev
RESEARCH NEWS 2019-05-31 Research News As anti-tau antibodies move through clinical trials, Biogen researchers led by Tien Dam publish results from the Phase 1b trial of their antibody BIIB092 in the June Lancet Neurology. This antibody recognizes N-terminal fragments of tau, whi
RESEARCH NEWS 2019-06-05 Research News Few studies have examined what happens to adult-born neurons in frontotemporal dementia. In the May 27 Journal of Neuroscience, researchers led by María Llorens-Martín at the Universidad Autónoma de Madrid report that in a mouse model of the
RESEARCH NEWS 2019-06-07 Research News This story was updated June 10, 2019. The side effects that emerged in AD trials have given γ-secretase inhibitors a bad rap. According to a paper published May 29 in Science Translational Medicine, it might be time to take a second look. Re
RESEARCH NEWS 2019-06-13 Research News Epidemiology has tied infection with hepatitis C to an increased risk for Parkinson’s disease. But what happens when the infection is treated? By surveying medical records of nearly 200,000 patients, researchers led by Ying-Zu Huang and Rou-
RESEARCH NEWS 2019-06-14 Research News Does the head honcho of genetic Alzheimer’s risk occlude contributions of smaller genes? In the June 10 JAMA Neurology, researchers led by Lindsay Farrer at Boston University exposed some hidden variants that have languished in the shadow of
CONFERENCE COVERAGE 2018-12-04 Conference Coverage Indigenous Australian people opened the 11th International Conference on Frontotemporal Dementia at the International Convention Center, Sydney, November 11–14. Koomurri performers welcomed more than 600 attendees from 37 countries. Ch
CONFERENCE COVERAGE 2018-11-14 Conference Coverage Clinicians have been eagerly awaiting results of the enormous Imaging Dementia–Evidence for Amyloid Scanning (IDEAS) study, which may determine whether amyloid scans will be covered by insurance. Preliminary findings previously indica
CONFERENCE COVERAGE 2018-12-20 Conference Coverage Part 1 of a two-part story. Click here for Part 2. Tau comes in many forms, and calls many locations home, both inside and outside of cells. Which is the one that wreaks damage to neurons, and where exactly does it reside? Researchers
RESEARCH NEWS 2019-03-01 Research News TDP-43 proteinopathy rears its ugly head in most patients with amyotrophic lateral sclerosis and nearly half of those with frontotemporal dementia, not to mention many cases of Alzheimer’s disease and traumatic brain injury. Still, it’s been
CONFERENCE COVERAGE 2018-07-17 Conference Coverage When tau strays into neuronal synapses, microglia see food. That is one possible interpretation from a handful of presentations at the joint Keystone symposia—Advances in Neurodegenerative Disease Research and Therapy / New Frontiers i
